Latest Articles
This Week in Oncology: FDA Approval Shakeups and Key SITC 2025 Data - CancerNetwork
This Week in Oncology: FDA Approval Shakeups and Key SITC 2025 Data CancerNetwork
Published: Nov. 16, 2025, 5:11 p.m.
Patients with early Endometrial Cancer who don't undergo Hysterectomy have Higher Mortality: Study - Medical Dialogues
Patients with early Endometrial Cancer who don't undergo Hysterectomy have Higher Mortality: Study Medical Dialogues
Published: Nov. 16, 2025, 4:30 p.m.
Ane Gerda Zahl Eriksson: SENSOR-LIIFE - Advancing Exercise Research in Endometrial Cancer Survivor - Oncodaily
Ane Gerda Zahl Eriksson: SENSOR-LIIFE - Advancing Exercise Research in Endometrial Cancer Survivor Oncodaily
Published: Nov. 16, 2025, 9:57 a.m.
Endometrial Cancer Cure Rate: What Patients Need to Know in 2025 - Oncodaily
Endometrial Cancer Cure Rate: What Patients Need to Know in 2025 Oncodaily
Published: Nov. 16, 2025, 8:17 a.m.
FDA approves Promega’s OncoMate test to guide personalised treatment for endometrial cancer - Indian Pharma Post
FDA approves Promega’s OncoMate test to guide personalised treatment for endometrial cancer Indian Pharma Post
Published: Nov. 14, 2025, 3:26 p.m.
‘I was rushed to hospital with sepsis after years of crippling pain – doctors even feared it could be cancer before discovering the real cause’ - needtoknow.co.uk
‘I was rushed to hospital with sepsis after years of crippling pain – doctors even feared it could be cancer before discovering the real cause’ needtoknow.co.uk
Published: Nov. 14, 2025, 9:26 a.m.
Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression - Cancer Cell International
Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression Cancer Cell International
Published: Nov. 14, 2025, 4:25 a.m.
Woman's Bloating & Indigestion Turned Out To Be Ovarian Cancer - SurvivorNet
Woman's Bloating & Indigestion Turned Out To Be Ovarian Cancer SurvivorNet
Published: Nov. 14, 2025, 2:15 a.m.
Acrivon Therapeutics Advances ACR-368 in Phase 2b Trial for Endometrial Cancer and Prepares for Initial Data on ACR-2316 - Quiver Quantitative
Acrivon Therapeutics Advances ACR-368 in Phase 2b Trial for Endometrial Cancer and Prepares for Initial Data on ACR-2316 Quiver Quantitative
Published: Nov. 13, 2025, 9:25 p.m.
Insufficient Endometrial Biopsy Increases Cancer Risk - European Medical Journal
Insufficient Endometrial Biopsy Increases Cancer Risk European Medical Journal
Published: Nov. 13, 2025, 1:03 p.m.
Link copied to clipboard!